Table 2.

The women's self-reported side effects.

ID	Hot flashes	Arthralgias	Sleep disturbance	Fatigue	Weight gain or loss	Anxiety/depressive symptoms	“Female things”	Cognitive problems
1	B	Both		I	B	BDI-II, P		B
2		Both	I		B	BDI-II, P	Both	Both
3*		Both			B	BDI-II, P, I	BCPT	I
4	Both		I		B	BDI-II, P	Both	B
5	B				Both	BDI-II, P		B
6	Both	B	I			BDI-II, P	B	B
7	Both	B			B	BDI-II, P	B	B
8	Both	B	I	I	Both	BDI-II, P		Both
9	Both	B	I	I	B	BDI-II, P		B
10	Both	Both	I			BDI-II, P	B	B
11	B	Both			B	BDI-II, P	B	B
12	Both	Both	I	I		BDI-II, P		Both

Arthralgias were defined as aches, pains, and joint pains. “Female things” were defined as vaginal itching, vaginal bleeding, vaginal discharge, or pain with intercourse.

B: Symptoms reported by the participant on the Breast Cancer Prevention Trial (BCPT) Symptom Checklist only.

I: Symptoms reported by the participant during the interview only.

Both: Symptoms reported by the participant in both the interview and the BCPT.

P: Anxiety reported by the participant in the Profile of Mood States (POMS) Tension-Anxiety Subscale.

BDI-II: Depressive symptoms reported by the participant in the Beck Depression Inventory-II Scale.

*This participant was the only woman to specifically express depressive symptoms or anxiety in her interview.